While the Trump administration targets COVID-19-related research, a new report from the ECDC shows the benefits of ...

A drug usually used to help people recover from opioid addiction might also offer new hope for those suffering from long ...

"It's all in your head." For countless patients seeking answers to unexplained symptoms, this dismissive phrase from healthcare professionals triggers a cascade of harmful consequences.

COVID-19 cases are rising across Southeast Asia, driven by Omicron subvariants like JN.1, LF.7, and NB.1.8, with India ...

In a recent study, a research team from the Medical University of Vienna has gained new insights into post-COVID syndrome ...

In a recent study, a research team from the Medical University of Vienna has gained new insights into post-COVID syndrome ...

A new book shows how Johnson & Johnson has pushed misleading narratives and suppressed inconvenient findings to sell its ...

The global pandemic may have officially waned, but for millions around the world, the aftershocks of COVID-19 remain an ...

Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...

Surgeons in southern California successfully completed the world's first-ever human bladder transplant on 41-year-old Oscar ...

Revolutionizing Alzheimer's care, Zunveyl minimizes GI and sleep side effects. Discover its market potential and why it's ...

Low-dose naltrexone (LDN) has been identified as a potential treatment for Long COVID after a Griffith University study, ...